Lipella Pharmaceuticals Inc. Share Price & Technical Analysis
LIPO · $0.10 (-28.57%)
Healthcare / Biotechnology
$0.10
-28.57%
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planu…
Price chart
Seasonality
May has 1 positive and 2 negative years (last 5 years shown)
0% return in 2026, -109% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 50% | 0% | -50% | 0% | – | – | – | – | – | – | – | – | 0% |
| 25 | -13% | 7% | -14% | 0% | 8% | -69% | -22% | -14% | 0% | -33% | -25% | -33% | -209% |
| 24 | 5% | 6% | -33% | 7% | -11% | -29% | 79% | -40% | 12% | -18% | 0% | -3% | -25% |
| 23 | -27% | -14% | -4% | 27% | -12% | 8% | -1% | -6% | -25% | -36% | 3% | -8% | -94% |
| 22 | – | – | – | – | – | – | – | – | – | – | – | -46% | -46% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$194.07K
P/E ratio
—
52W high
$3.17
52W low
$0.02
Volume
10,000
Beta
0.84
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Lipella Pharmaceuticals Inc. share price today?
- Lipella Pharmaceuticals Inc. (LIPO) last traded around $0.10 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LIPO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LIPO. Download the app for real-time alerts.
- How can I analyze Lipella Pharmaceuticals Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.